USPTO serial 79225073
PENTAMBODY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 5, 2019
- Examiner
- JOHN, CRISTEL M
- Law office
- Historical data usage
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with PENTAMBODY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
BEIJING HANMI PHARMACEUTICAL CO., LTD.
Beijing, CN
Other trademarks owned by BEIJING HANMI PHARMACEUTICAL CO., LTD.
BEIJING HANMI PHARMACEUTICAL CO., LTD.
Beijing, CN
Other trademarks owned by BEIJING HANMI PHARMACEUTICAL CO., LTD.
BEIJING HANMI PHARMACEUTICAL CO., LTD.
Beijing, CN
Other trademarks owned by BEIJING HANMI PHARMACEUTICAL CO., LTD.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kenneth A. Knox
Kenneth A. Knox Perilla Knox & Hildebrandt LLP5871 Glenridge DriveSuite 350Atlanta, GA 30328-5376Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicines for human purposes, pharmaceutical preparations, drugs for medical purposes, biological preparations for medical purposes, biochemical drugs, and pharmaceutical preparations in the form of injection, each of which being, namely, for treating one or more of autoimmune diseases, immune response against grafts, allergic reactions, neurodegenerative diseases, neoplastic diseases and cellular proliferative disorders, arthritis, rheumatoid arthritis, psoriasis, multiple sclerosis (MS), ulcerative colitis, Crohn's disease, systemic lupus erythematosus (SLE), glomerulonephritis, dilated cardiomyopathy-like diseases, Sjogren's syndrome, allergic contact dermatitis, polymyositis, scleroderma, periarteritis nodosa, rheumatic fever, vitiligo, insulin-dependent diabetes mellitus, Behcet's syndrome, chronic thyroiditis, Parkinson's disease, Huntington's disease, Machado-Joseph disease, amyotrophic lateral sclerosis (ALS), Creutzfeldt - Jakob disease, leukemia, lymphoma, myeloma, brain tumors, head and neck squamous cell carcinoma, non-small cell lung cancer (NSCLC), nasopharyngeal cancer, esophageal cancer, stomach cancer, pancreatic cancer, gallbladder cancer, liver cancer, colorectal cancer, breast cancer, ovarian cancer, cervical cancer, endometrial cancer, uterine sarcoma, prostate cancer, bladder cancer, renal cell carcinoma, melanoma, and combinations thereof; nutritional supplements and dietetic substances adapted for medical use, namely, dietetic foods adapted for medical use and dietetic beverages adapted for medical use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BEIJING HANMI PHARMACEUTICAL CO., LTD.
- Other trademarks owned by BEIJING HANMI PHARMACEUTICAL CO., LTD.
- Other trademarks owned by BEIJING HANMI PHARMACEUTICAL CO., LTD.
- Other trademarks in Class 005
- Similar marks named PENTAMBODY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 12, 2026 | PR71 | POST REGISTRATION ACTION MAILED - SEC.71 | — |
| Aug 10, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 30, 2026 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Nov 5, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Apr 24, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 2, 2020 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Mar 2, 2020 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Feb 5, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 5, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 20, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 20, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 31, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 31, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 31, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 18, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 5, 2019 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jun 20, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 20, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 19, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 19, 2019 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jun 17, 2019 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jun 17, 2019 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Jun 17, 2019 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Jun 17, 2019 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Dec 17, 2018 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Dec 17, 2018 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 17, 2018 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 14, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 14, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 14, 2018 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 9, 2018 | ALIE | ASSIGNED TO LIE | — |
| Oct 31, 2018 | NREV | NOTICE OF REVIVAL - MAILED | — |
| Oct 30, 2018 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 30, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 30, 2018 | PETG | PETITION TO REVIVE-GRANTED | — |
| Oct 30, 2018 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Oct 1, 2018 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 1, 2018 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 24, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 3, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 2, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 29, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 28, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 23, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 19, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 19, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 18, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |